Origin and function of myofibroblasts in kidney fibrosis

Nature Medicine

Volumn 19, Issue 8, 2013, Pages 1047-1053

  Lebleu, Valerie S ^a,b   Taduri, Gangadhar ^b   O'Connell, Joyce ^b   Teng, Yingqi ^b   Cooke, Vesselina G ^b   Woda, Craig ^b   Sugimoto, Hikaru ^a,b   Kalluri, Raghu ^a,b,c,d  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

^d MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; PROTEOCHONDROITIN SULFATE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY LABELING; ARTICLE; BONE MARROW TRANSPLANTATION; CELL DIFFERENTIATION; CELL FUNCTION; CELL POPULATION; CELL PROLIFERATION; CELL SURFACE; CELL TRANSFORMATION; CHIMERA; CONTROLLED STUDY; ENDOTHELIAL MESENCHYMAL TRANSITION; EPITHELIAL MESENCHYMAL TRANSITION; FEMALE; GENE DELETION; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; KIDNEY FIBROSIS; MALE; MESENCHYMAL STEM CELL; MOUSE; MYOFIBROBLAST; NONHUMAN; PERICYTE; PRIORITY JOURNAL; PROMOTER REGION; WHOLE BODY RADIATION;

ACTINS; ANIMALS; ANTIGENS; BONE MARROW CELLS; CELL DIFFERENTIATION; CELL PROLIFERATION; EPITHELIAL-MESENCHYMAL TRANSITION; FEMALE; FIBROSIS; KIDNEY; KIDNEY DISEASES; MALE; MESENCHYMAL STROMAL CELLS; MICE; MYOFIBROBLASTS; PERICYTES; PROTEIN-SERINE-THREONINE KINASES; PROTEOGLYCANS; RECEPTOR, PLATELET-DERIVED GROWTH FACTOR BETA; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; SIGNAL TRANSDUCTION;

MUS;

EID: 84882289111     PISSN: 10788956     EISSN: 1546170X     Source Type: Journal    
DOI: 10.1038/nm.3218     Document Type: Article

References (39)

1. Gabbiani, G. The myofibroblast in wound healing and fibrocontractive diseases. J. Pathol. 200, 500-503 (2003).
2. Sugimoto, H., Mundel, T.M., Kieran, M.W. & Kalluri, R. Identification of fibroblast heterogeneity in the tumor microenvironment. Cancer Biol. Ther. 5, 1640-1646 (2006).
3. Meran, S. & Steadman, R. Fibroblasts and myofibroblasts in renal fibrosis. Int. J. Exp. Pathol. 92, 158-167 (2011).
4. Humphreys, B.D. et al. Fate tracing reveals the pericyte and not epithelial origin of myofibroblasts in kidney fibrosis. Am. J. Pathol. 176, 85-97 (2010).
5. Lin, S.L., Kisseleva, T., Brenner, D.A. & Duffield, J.S. Pericytes and perivascular fibroblasts are the primary source of collagen-producing cells in obstructive fibrosis of the kidney. Am. J. Pathol. 173, 1617-1627 (2008).
6. Rønnov-Jessen, L., Petersen, O.W., Koteliansky, V.E. & Bissell, M.J. The origin of the myofibroblasts in breast cancer. Recapitulation of tumor environment in culture unravels diversity and implicates converted fibroblasts and recruited smooth muscle cells. J. Clin. Invest. 95, 859-873 (1995).
7. Armulik, A., Genove, G. & Betsholtz, C. Pericytes: developmental, physiological, and pathological perspectives, problems, and promises. Dev. Cell 21, 193-215 (2011).
8. Hall, A.P. Review of the pericyte during angiogenesis and its role in cancer and diabetic retinopathy. Toxicol. Pathol. 34, 763-775 (2006).
9. Iwano, M. et al. Evidence that fibroblasts derive from epithelium during tissue fibrosis. J. Clin. Invest. 110, 341-350 (2002).
10. Kalluri, R. & Neilson, E.G. Epithelial-mesenchymal transition and its implications for fibrosis. J. Clin. Invest. 112, 1776-1784 (2003).
11. Zeisberg, M. & Kalluri, R. Fibroblasts emerge via epithelial-mesenchymal transition in chronic kidney fibrosis. Front. Biosci. 13, 6991-6998 (2008).
12. Zeisberg, M. & Kalluri, R. The role of epithelial-to-mesenchymal transition in renal fibrosis. J. Mol. Med. 82, 175-181 (2004).
13. Li, J., Qu, X. & Bertram, J.F. Endothelial-myofibroblast transition contributes to the early development of diabetic renal interstitial fibrosis in streptozotocin-induced diabetic mice. Am. J. Pathol. 175, 1380-1388 (2009).
14. Zeisberg, E.M., Potenta, S.E., Sugimoto, H., Zeisberg, M. & Kalluri, R. Fibroblasts in kidney fibrosis emerge via endothelial-to-mesenchymal transition. J. Am. Soc. Nephrol. 19, 2282-2287 (2008).
15. Broekema, M. et al. Bone marrow-derived myofibroblasts contribute to the renal interstitial myofibroblast population and produce procollagen I after ischemia/reperfusion in rats. J. Am. Soc. Nephrol. 18, 165-175 (2007).
16. Li, J., Deane, J.A., Campanale, N.V., Bertram, J.F. & Ricardo, S.D. The contribution of bone marrow-derived cells to the development of renal interstitial fibrosis. Stem Cells 25, 697-706 (2007).
17. LeBleu, V.S. et al. Identification of human epididymis protein-4 as a fibroblast-derived mediator of fibrosis. Nat. Med. 19, 227-231 (2013).
18. LeBleu, V. et al. Stem cell therapies benefit Alport syndrome. J. Am. Soc. Nephrol. 20, 2359-2370 (2009).
19. LeBleu, V.S., Sugimoto, H., Miller, C.A., Gattone, V.H. II & Kalluri, R. Lymphocytes are dispensable for glomerulonephritis but required for renal interstitial fibrosis in matrix defect induced Alport renal disease. Lab. Invest. 88, 284-292 (2008).
20. Leask, A. & Abraham, D.J. TGF-β signaling and the fibrotic response. FASEB J. 18, 816-827 (2004).
21. Chytil, A., Magnuson, M.A., Wright, C.V. & Moses, H.L. Conditional inactivation of the TGF-β type II receptor using Cre:Lox. Genesis 32, 73-75 (2002).
22. Ozerdem, U., Grako, K.A., Dahlin-Huppe, K., Monosov, E. & Stallcup, W.B. NG2 proteoglycan is expressed exclusively by mural cells during vascular morphogenesis. Dev. Dyn. 222, 218-227 (2001).
23. Bergers, G. & Song, S. The role of pericytes in blood-vessel formation and maintenance. Neuro-oncol. 7, 452-464 (2005).
24. Cooke, V.G. et al. Pericyte depletion results in hypoxia-associated epithelial-to-mesenchymal transition and metastasis mediated by met signaling pathway. Cancer Cell 21, 66-81 (2012).
25. Díaz-Flores, L. et al. Pericytes. Morphofunction, interactions and pathology in a quiescent and activated mesenchymal cell niche. Histol. Histopathol. 24, 909-969 (2009).
26. Hirschi, K.K. & D'Amore, P.A. Pericytes in the microvasculature. Cardiovasc. Res. 32, 687-698 (1996).
27. Lindahl, P., Johansson, B.R., Leveen, P. & Betsholtz, C. Pericyte loss and microaneurysm formation in PDGF-B-deficient mice. Science 277, 242-245 (1997).
28. Song, S., Ewald, A.J., Stallcup, W., Werb, Z. & Bergers, G. PDGFRβ+ perivascular progenitor cells in tumours regulate pericyte differentiation and vascular survival. Nat. Cell Biol. 7, 870-879 (2005).
29. Foo, S.S. et al. Ephrin-B2 controls cell motility and adhesion during blood-vessel-wall assembly. Cell 124, 161-173 (2006).
30. Abraham, S., Kogata, N., Fassler, R. & Adams, R.H. Integrin β1 subunit controls mural cell adhesion, spreading, and blood vessel wall stability. Circ. Res. 102, 562-570 (2008).
31. Kriz, W., Kaissling, B. & Le Hir, M. Epithelial-mesenchymal transition (EMT) in kidney fibrosis: fact or fantasy? J. Clin. Invest. 121, 468-474 (2011).
32. Liu, Y. New insights into epithelial-mesenchyal transition in kidney fibrosis. J. Am. Soc. Nephrol. 21, 212-222 (2010).
33. Sugimoto, H. et al. Activin-like kinase 3 is important for kidney regeneration and reversal of fibrosis. Nat. Med. 18, 396-404 (2012).
34. Collett, G.D. & Canfield, A.E. Angiogenesis and pericytes in the initiation of ectopic calcification. Circ. Res. 96, 930-938 (2005).
35. Hashimoto, N. et al. Endothelial-mesenchymal transition in bleomycin-induced pulmonary fibrosis. Am. J. Respir. Cell Mol. Biol. 43, 161-172 (2010).
36. Zeisberg, E.M. et al. Endothelial-to-mesenchymal transition contributes to cardiac fibrosis. Nat. Med. 13, 952-961 (2007).
37. Rock, J.R. et al. Multiple stromal populations contribute to pulmonary fibrosis without evidence for epithelial to mesenchymal transition. Proc. Natl. Acad. Sci. USA 108, E1475-E1483 (2011).
38. Zeisberg, M. et al. BMP-7 counteracts TGF-β1-induced epithelial-to-mesenchymal transition and reverses chronic renal injury. Nat. Med. 9, 964-968 (2003).
39. Tondreau, T. et al. Isolation of BM mesenchymal stem cells by plastic adhesion or negative selection: phenotype, proliferation kinetics and differentiation potential. Cytotherapy 6, 372-379 (2004).